| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophic cardiomyopathy.
|
N Engl J Med
|
2003
|
5.17
|
|
2
|
Hypertrophic cardiomyopathy is predominantly a disease of left ventricular outflow tract obstruction.
|
Circulation
|
2006
|
3.82
|
|
3
|
Coronary microvascular dysfunction and prognosis in hypertrophic cardiomyopathy.
|
N Engl J Med
|
2003
|
2.92
|
|
4
|
Late sodium current inhibition reverses electromechanical dysfunction in human hypertrophic cardiomyopathy.
|
Circulation
|
2012
|
2.78
|
|
5
|
Long-term effects of surgical septal myectomy on survival in patients with obstructive hypertrophic cardiomyopathy.
|
J Am Coll Cardiol
|
2005
|
2.43
|
|
6
|
Mitral valve abnormalities identified by cardiovascular magnetic resonance represent a primary phenotypic expression of hypertrophic cardiomyopathy.
|
Circulation
|
2011
|
2.04
|
|
7
|
Clinical features and outcome of hypertrophic cardiomyopathy associated with triple sarcomere protein gene mutations.
|
J Am Coll Cardiol
|
2010
|
1.80
|
|
8
|
Prognostic significance of left atrial size in patients with hypertrophic cardiomyopathy (from the Italian Registry for Hypertrophic Cardiomyopathy).
|
Am J Cardiol
|
2006
|
1.66
|
|
9
|
The case for myocardial ischemia in hypertrophic cardiomyopathy.
|
J Am Coll Cardiol
|
2009
|
1.66
|
|
10
|
Association of persistent right ventricular dysfunction at hospital discharge after acute pulmonary embolism with recurrent thromboembolic events.
|
Arch Intern Med
|
2006
|
1.56
|
|
11
|
Hypertrophic cardiomyopathy phenotype revisited after 50 years with cardiovascular magnetic resonance.
|
J Am Coll Cardiol
|
2009
|
1.48
|
|
12
|
Timing and significance of exercise-induced left ventricular outflow tract pressure gradients in hypertrophic cardiomyopathy.
|
Am J Cardiol
|
2010
|
1.46
|
|
13
|
Validation of pixel-wise parametric mapping of myocardial blood flow with ¹³NH₃ PET in patients with hypertrophic cardiomyopathy.
|
Eur J Nucl Med Mol Imaging
|
2015
|
1.41
|
|
14
|
[Management of refractory symptoms in hypertrophic cardiomyopathy with restrictive pathophysiology: novel perspectives for ranolazine].
|
G Ital Cardiol (Rome)
|
2012
|
1.38
|
|
15
|
Clinical profile of stroke in 900 patients with hypertrophic cardiomyopathy.
|
J Am Coll Cardiol
|
2002
|
1.18
|
|
16
|
The familial hypertrophic cardiomyopathy-associated myosin mutation R403Q accelerates tension generation and relaxation of human cardiac myofibrils.
|
J Physiol
|
2008
|
1.14
|
|
17
|
The dilemma of left ventricular outflow tract obstruction and sudden death in hypertrophic cardiomyopathy: do patients with gradients really deserve prophylactic defibrillators?
|
Eur Heart J
|
2006
|
1.13
|
|
18
|
Prevalence and clinical correlates of QT prolongation in patients with hypertrophic cardiomyopathy.
|
Eur Heart J
|
2011
|
1.11
|
|
19
|
Usefulness of bedside testing for brain natriuretic peptide to identify right ventricular dysfunction and outcome in normotensive patients with acute pulmonary embolism.
|
Am J Cardiol
|
2006
|
1.10
|
|
20
|
Pharmacological treatment options for hypertrophic cardiomyopathy: high time for evidence.
|
Eur Heart J
|
2012
|
1.08
|
|
21
|
A molecular screening strategy based on beta-myosin heavy chain, cardiac myosin binding protein C and troponin T genes in Italian patients with hypertrophic cardiomyopathy.
|
J Cardiovasc Med (Hagerstown)
|
2006
|
1.01
|
|
22
|
The coronary circulation and blood flow in left ventricular hypertrophy.
|
J Mol Cell Cardiol
|
2011
|
0.99
|
|
23
|
Echocardiography in patients with hypertrophic cardiomyopathy: usefulness of old and new techniques in the diagnosis and pathophysiological assessment.
|
Cardiovasc Ultrasound
|
2010
|
0.96
|
|
24
|
Prevalence and clinical profile of troponin T mutations among patients with hypertrophic cardiomyopathy in tuscany.
|
Am J Cardiol
|
2003
|
0.95
|
|
25
|
Microvascular dysfunction, myocardial ischemia, and progression to heart failure in patients with hypertrophic cardiomyopathy.
|
J Cardiovasc Transl Res
|
2009
|
0.95
|
|
26
|
Efficacy of catheter ablation for atrial fibrillation in hypertrophic cardiomyopathy: impact of age, atrial remodelling, and disease progression.
|
Europace
|
2010
|
0.94
|
|
27
|
Determinants of echocardiographic left atrial volume: implications for normalcy.
|
Eur J Echocardiogr
|
2011
|
0.93
|
|
28
|
Left ventricular apical ballooning syndrome as a novel cause of acute mitral regurgitation.
|
J Am Coll Cardiol
|
2007
|
0.92
|
|
29
|
Effectiveness of a multidisciplinary chest pain unit for the assessment of coronary syndromes and risk stratification in the Florence area.
|
Am Heart J
|
2002
|
0.91
|
|
30
|
Spatial relationship between coronary microvascular dysfunction and delayed contrast enhancement in patients with hypertrophic cardiomyopathy.
|
J Nucl Med
|
2008
|
0.91
|
|
31
|
Early results of sarcomeric gene screening from the Egyptian National BA-HCM Program.
|
J Cardiovasc Transl Res
|
2012
|
0.89
|
|
32
|
'End-stage' hypertrophic cardiomyopathy: from mystery to model.
|
Nat Clin Pract Cardiovasc Med
|
2007
|
0.89
|
|
33
|
Metabolomic fingerprint of heart failure in humans: a nuclear magnetic resonance spectroscopy analysis.
|
Int J Cardiol
|
2013
|
0.88
|
|
34
|
MR Imaging in Hypertrophic Cardiomyopathy: From Magnet to Bedside.
|
Radiology
|
2014
|
0.88
|
|
35
|
Effect of comorbidity on coronary reperfusion strategy and long-term mortality after acute myocardial infarction.
|
Am Heart J
|
2006
|
0.86
|
|
36
|
Distal extremity pain as a presenting feature of Fabry's disease.
|
Arthritis Care Res (Hoboken)
|
2010
|
0.86
|
|
37
|
Early discharge after acute myocardial infarction in the current clinical practice. Community data from the AMI-Florence Registry, Italy.
|
Int J Cardiol
|
2006
|
0.86
|
|
38
|
Effects of myocardial fibrosis assessed by MRI on dynamic left ventricular outflow tract obstruction in patients with hypertrophic cardiomyopathy: a retrospective database analysis.
|
BMJ Open
|
2012
|
0.85
|
|
39
|
Usefulness and safety of transcatheter ablation of atrial fibrillation in patients with hypertrophic cardiomyopathy.
|
Am J Cardiol
|
2007
|
0.85
|
|
40
|
The Italian Registry for hypertrophic cardiomyopathy: a nationwide survey.
|
Am Heart J
|
2005
|
0.84
|
|
41
|
Pre-discharge B-type natriuretic peptide predicts early recurrence of decompensated heart failure in patients admitted to a general medical unit.
|
Eur J Heart Fail
|
2005
|
0.83
|
|
42
|
Relationship of ECG findings to phenotypic expression in patients with hypertrophic cardiomyopathy: a cardiac magnetic resonance study.
|
Int J Cardiol
|
2012
|
0.82
|
|
43
|
The left ventricular outflow in hypertrophic cardiomyopathy: from structure to function.
|
J Cardiovasc Transl Res
|
2009
|
0.81
|
|
44
|
Prevalence and clinical significance of acquired left coronary artery fistulas after surgical myectomy in patients with hypertrophic cardiomyopathy.
|
J Thorac Cardiovasc Surg
|
2010
|
0.81
|
|
45
|
Determinants of treatment strategies and survival in acute myocardial infarction: a population-based study in the Florence district, Italy: results of the acute myocardial infarction Florence registry (AMI-Florence).
|
Eur Heart J
|
2003
|
0.81
|
|
46
|
Coronary microvascular dysfunction is an early feature of cardiac involvement in patients with Anderson-Fabry disease.
|
Eur J Heart Fail
|
2013
|
0.80
|
|
47
|
Hypertrophic cardiomyopathy: The need for randomized trials.
|
Glob Cardiol Sci Pract
|
2013
|
0.80
|
|
48
|
Therapeutic implications of contractile reserve elicited by dobutamine echocardiography in symptomatic, low-gradient aortic stenosis.
|
Ital Heart J
|
2003
|
0.80
|
|
49
|
Hypertrophic cardiomyopathy in the community: why we should care.
|
Nat Clin Pract Cardiovasc Med
|
2005
|
0.78
|
|
50
|
Prognostic value of N-terminal pro-brain natriuretic Peptide in outpatients with hypertrophic cardiomyopathy.
|
Am J Cardiol
|
2013
|
0.78
|
|
51
|
Improving survival rates of patients with idiopathic dilated cardiomyopathy in Tuscany over 3 decades: impact of evidence-based management.
|
Circ Heart Fail
|
2013
|
0.78
|
|
52
|
β Blockers for prevention of exercise-induced left ventricular outflow tract obstruction in patients with hypertrophic cardiomyopathy.
|
Am J Cardiol
|
2012
|
0.78
|
|
53
|
Myocardial bridging and sudden death in hypertrophic cardiomyopathy: Salome drops another veil.
|
Eur Heart J
|
2009
|
0.78
|
|
54
|
Relationship between atrial fibrillation and blunted hyperemic myocardial blood flow in patients with hypertrophic cardiomyopathy.
|
J Nucl Cardiol
|
2009
|
0.77
|
|
55
|
Molecular modeling of disease causing mutations in domain C1 of cMyBP-C.
|
PLoS One
|
2013
|
0.77
|
|
56
|
Response to letter regarding article, "Late sodium current inhibition reverses electromechanical dysfunction in human hypertrophic cardiomyopathy".
|
Circulation
|
2013
|
0.77
|
|
57
|
[Disease progression and systolic dysfunction in patients with hypertrophic cardiomyopathy: genetic basis, pathophysiology and clinical presentation].
|
G Ital Cardiol (Rome)
|
2011
|
0.76
|
|
58
|
Midventricular obstruction and clinical decision-making in obstructive hypertrophic cardiomyopathy.
|
Herz
|
2006
|
0.76
|
|
59
|
Hemodynamic progression and outcome of asymptomatic aortic stenosis in primary care.
|
Am J Cardiol
|
2011
|
0.76
|
|
60
|
Chagas disease as a cause of heart failure and ventricular arrhythmias in patients long removed from endemic areas: an emerging problem in Europe.
|
J Cardiovasc Med (Hagerstown)
|
2015
|
0.76
|
|
61
|
[Myocardial hypoperfusion due to microvascular dysfunction in hypertrophic cardiomyopathy: role of positron emission tomography].
|
Zhonghua Xin Xue Guan Bing Za Zhi
|
2009
|
0.76
|
|
62
|
Reply: Obstructive sleep apnea and hypertrophic cardiomyopathy: obiter dictum or more?
|
J Am Coll Cardiol
|
2014
|
0.75
|
|
63
|
ECG-based screening: not only for athletes.
|
Eur Heart J
|
2007
|
0.75
|
|
64
|
[Assessment of left ventricular outflow tract obstruction according to the latest European guidelines on hypertrophic cardiomyopathy].
|
G Ital Cardiol (Rome)
|
2015
|
0.75
|
|
65
|
Looking for hypertrophic cardiomyopathy in the community: why is it important?
|
J Cardiovasc Transl Res
|
2009
|
0.75
|
|
66
|
Calcified left ventricular endomyocardial fibrosis.
|
J Heart Valve Dis
|
2012
|
0.75
|
|
67
|
Editors' page.
|
Glob Cardiol Sci Pract
|
2013
|
0.75
|
|
68
|
Systemic arterial waveform analysis and assessment of blood flow during extracorporeal circulation.
|
Perfusion
|
2006
|
0.75
|
|
69
|
[Clinical relevance of genetic testing in hypertrophic cardiomyopathy].
|
Recenti Prog Med
|
2011
|
0.75
|
|
70
|
An Investigation of the Molecular Mechanism of Double cMyBP-C Mutation in a Patient with End-Stage Hypertrophic Cardiomyopathy.
|
J Cardiovasc Transl Res
|
2015
|
0.75
|
|
71
|
["African sickness" and the heart: the mystery of endomyocardial fibrosis].
|
G Ital Cardiol (Rome)
|
2011
|
0.75
|
|
72
|
Hypertrophic cardiomyopathy at 50.
|
J Cardiovasc Transl Res
|
2009
|
0.75
|
|
73
|
New concepts in hypertrophic cardiomyopathies.
|
Circulation
|
2002
|
0.75
|
|
74
|
Dynamic assessment of 'valvular reserve capacity' in patients with rheumatic mitral stenosis.
|
Eur Heart J Cardiovasc Imaging
|
2011
|
0.75
|